Time from first presentation in primary care to treatment of symptomatic colorectal cancer: Effect on disease stage and survival

British Journal of Cancer

Volumn 111, Issue 3, 2014, Pages 461-469

  Murchie, P ^a   Raja, E A ^a   Brewster, D H ^b   Campbell, N C ^a   Ritchie, L D ^a   Robertson, R ^c   Samuel, L ^d   Gray, N ^a   Lee, A J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b INFORMATION SERVICES DIVISION   (United Kingdom)

^c Scottish Collaboration for Public Health Research and Policy (SCPHRP)   (United Kingdom)

^d ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PROGNOSIS; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; COLORECTAL CANCER; CONTROLLED STUDY; EMERGENCY CARE; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SURVIVAL TIME; THERAPY DELAY; TIME TO TREATMENT; UNITED KINGDOM;

AGED; COLORECTAL NEOPLASMS; DELAYED DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84905225778     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.352     Document Type: Article

References (30)

1. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, Parkin DM, Wardle J, Duffy SW, Cuzick J (2010) Once-only flexible sigmoidoscopy screening in prevention of CRC: a multicentre randomised controlled trial. Lancet 375: 1624-1633.
2. Brewster DH, Stockton D, Harvey J, Mackay M (2002) Reliability of cancer registration data in Scotland, 1997. Eur J Cancer 38: 414-417.
3. Brewster DH, Stockton DL (2008) Ascertainment of breast cancer by the Scottish Cancer Registry: an assessment based on comparison with five independent breast cancer trials databases. Breast 17: 106-108.
4. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40: 373-383.
5. Department of Health (2007) Cancer Reform Strategy. Department of Health: London, England.
6. Dupout WD (2008) Statistical Modelling for Biomedical Researchers. 2nd edn, Cambridge University Press: Cambridge, UK.
7. Harley K, Jones C (1996) Quality of Scottish Morbidity Record (SMR) date. Health Bull (Edinb) 54: 410-417.
8. Hess KR (1995) Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med 14: 1707-1723.
9. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E (2007) Screening for CRC using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 1: CD001216.
10. Information and Statistics Division (ISD) (2013) of the NHS in Scotland website: (accessed 7 January 2013). http://www.isdscotland.org/.
11. Iversen LH, Antonsen S, Laurberg S, Lautrup MD (2009) Therapeutic delay reduces survival of rectal cancer but not of colonic cancer. Br J Surg 96: 1183-1189.
12. Kendrick S (1997) The development of record linkage in Scotland: the responsive application of probability matching. In In record linkage techniques-1997: Proceedings of an International Workshop and Exposition, Arlington, VA, March 20-21, 1997, Alvey W, Jamerson B (eds) pp 319-332.
13. Federal Committee on Statistical Methodology, Office of Management and Budget: Washington DC, Available at http://www.fcsm.gov/working-papers/ skendrick.pdf.
14. Kendrick S, Clarke J (1993) The Scottish record linkage system. Health Bull 51: 72-79.
15. Morris R, Carstairs V (1991) Which deprivation? a comparison of selected deprivation indexes. J Public Health Med 13: 318-326.
16. Neal R (2009) Do diagnostic delays in cancer matter? Br J Cancer 101: S9-S12.
17. Ramos R, Esteva M, Cabeza E, Campillo C, Llobera J, Aguiló A (2007) Relationship of diagnostic and therapeutic delay with survival in CRC: a review. Eur J Cancer 43: 2467-2478.
18. Ramos R, Esteva M, Cabeza E, Llobera J, Ruiz A (2008) Lack of association between diagnostic and therapeutic delay and stage of CRC. Eur J Cancer 44: 510-521.
19. Richards MA (2009) The national awareness and early diagnosis initiative in England: assembling the evidence. Br J Cancer 101: S1-S4.
20. Robertson R, Campbell NC, Smith S, Donnan PT, Sullivan F, Duffy R, Ritchie LD, Millar D, Cassidy J, Munro A (2004) Factors influencing time from presentation to treatment of colorectal and breast cancer in urban and rural areas. Br J Cancer 90: 1479-1485.
21. Scottish Intercollegiate Guideline Network (SIGN) (2003) 67 Management of CRC: a national clinical guideline. SIGN: Edinburgh, UK.
22. Simon AE, Waller J, Robb K, Wardle J (2010) Patient delay in presentation of possible cancer symptoms: the contribution of knowledge and attitudes in a population sample from the United Kingdom. Cancer Epidemiol Biomarkers Prev 19(9): 2272-2277.
23. Simunovic M, Rempel E, Thérault ME, Baxter NN, Virnig BA, Meropol NJ, Levine MN (2009) Influence of delays to nonemergent colon cancer surgery on operative mortality, disease-specific survival and overall survival. Can J Surg 52: E79-E86.
24. Terhaarsive Droste J, Oort FA, van der Hulst RWM, Coupé VMH, Craanen ME, Meijer GA, Morsink LM, Visser O, van Wanrooij LJ, Mulder CJJ (2010) Does delay in diagnosing CRC in symptomatic patients affect tumour stage and survival. A population-based observational study. BMC Cancer 10: 332.
25. The Scottish Government. Better Cancer Care, An Action Plan: The Scottish Government, Edinburgh, UK, 2008.
26. Tønnesen H, Nielsen PR, Lauritzen JB, Møller AM (2009) Smoking and alcohol intervention before surgery: evidence for best practice. Br J Anaesth 102: 297-306.
27. Tørring ML, Frydenberg M, Hamilton W, Hansen RP, Lautrupe MD, Vedsted P (2012) Diagnostic interval and mortality in CRC: U-shaped association demonstrated for three different datasets. J Clin Epidemiol 65: 669-678.
28. Tørring ML, Frydenberg M, Hansen RP, Olesen F, Hamilton W, Vested P (2011) Time to diagnosis and mortality in CRC: a cohort study in primary care. Br J Cancer 104: 934-940.
29. Wattercheril J, Kramer JR, Richardson P, Havemann BD, Green LK, Le A, El-Serag HB (2008) Lagtimes in diagnosis and treatment of CRC: determinants and association with cancer stage and survival. Aliment Pharmacol Ther 28: 1166-1174.
30. Weller D, Vested P, Rubin G, Walter FM, Emery J, Scott S, Campbell C, Andersen RS, Hamilton W, Olesen F, Rose P, Nafees S, van Rijswijk E, Hiom S, Mutch C, Beyer M, Neal RD. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer (2012) 106: 1262-1267.